Education
About Us
Working with TipRanks
Follow Us
PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB
Total Valuation
PDS Biotechnology has a market cap or net worth of $48.93M. The enterprise value is $39.11M.
Market Cap$48.93M
Enterprise Value$39.11M
Share Statistics
PDS Biotechnology has 54,721,306 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding54,721,306
Owned by Insiders1.79%
Owned by Institutions0.91%
Financial Efficiency
PDS Biotechnology’s return on equity (ROE) is -1.98 and return on invested capital (ROIC) is -86.94%.
Return on Equity (ROE)-1.98
Return on Assets (ROA)-0.83
Return on Invested Capital (ROIC)-86.94%
Return on Capital Employed (ROCE)-1.28
Revenue Per Employee0.00
Profits Per Employee-1.57M
Employee Count24
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PDS Biotechnology is ―. PDS Biotechnology’s PEG ratio is 0.06.
PE Ratio―
PS Ratio0.00
PB Ratio3.13
Price to Fair Value3.13
Price to FCF-1.69
Price to Operating Cash Flow>-0.01
PEG Ratio0.06
Income Statement
In the last 12 months, PDS Biotechnology had revenue of 0.00 and earned -37.61M in profits. Earnings per share was -1.03.
Revenue0.00
Gross Profit-59.79K
Operating Income-36.32M
Pretax Income-38.48M
Net Income-37.61M
EBITDA-33.75M
Earnings Per Share (EPS)-1.03
Cash Flow
In the last 12 months, operating cash flow was -32.28M and capital expenditures 3.00, giving a free cash flow of -32.28M billion.
Operating Cash Flow-32.28M
Free Cash Flow-32.28M
Free Cash Flow per Share-0.59
Dividends & Yields
PDS Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.37
52-Week Price Change-59.91%
50-Day Moving Average0.91
200-Day Moving Average1.18
Relative Strength Index (RSI)51.95
Average Volume (3m)1.02M
Important Dates
PDS Biotechnology upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
PDS Biotechnology as a current ratio of 2.64, with Debt / Equity ratio of 0.82%
Current Ratio2.64
Quick Ratio2.64
Debt to Market Cap0.37
Net Debt to EBITDA0.59
Interest Coverage Ratio-7.77
Taxes
In the past 12 months, PDS Biotechnology has paid -869.17K in taxes.
Income Tax-869.17K
Effective Tax Rate0.02
Enterprise Valuation
PDS Biotechnology EV to EBITDA ratio is -1.17, with an EV/FCF ratio of -1.13.
EV to Sales0.00
EV to EBITDA-1.17
EV to Free Cash Flow-1.13
EV to Operating Cash Flow-1.13
Balance Sheet
PDS Biotechnology has $26.20M in cash and marketable securities with $17.97M in debt, giving a net cash position of $8.23M billion.
Cash & Marketable Securities$26.20M
Total Debt$17.97M
Net Cash$8.23M
Net Cash Per Share$0.15
Tangible Book Value Per Share$0.52
Margins
Gross margin is 50.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin50.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PDS Biotechnology is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.00
Price Target Upside934.48% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast29.95%